Anstiserum inhibition of propagating viruses

Biotechnology and Bioengineering

Volumn 55, Issue 3, 1997, Pages 542-546

  Lee, Yih ^a   Eisner, Symma D ^a   Yin, John ^a  

^a DARTMOUTH COLLEGE   (United States)

Author keywords

Diffusion; Imaging; Phage T7; Real time; Virus, antibody

Indexed keywords

ANTIBODY; ANTISERUM;

ARTICLE; BACTERIOPHAGE; CULTURE MEDIUM; DIFFUSION; EVOLUTION; IMMUNE SYSTEM; MATHEMATICAL MODEL; NONHUMAN; VIRION; VIROGENESIS; VIRUS CULTURE; VIRUS INHIBITION; VIRUS TITRATION;

ANTIBODIES; CELL CULTURE; DIFFUSION; MATHEMATICAL MODELS; MEDICAL IMAGING;

ANTISERUM INHIBITION; FICKIAN DIFFUSION; VIRAL PROPAGATION;

VIRUSES;

EID: 0030616028     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19970805)55:3<542::AID-BIT11>3.0.CO;2-I     Document Type: Article

References (48)

1. Adams, M. 1959. Bacteriophages. Interscience Publishers, New York.
2. Andrewes, C. H. and W. J. Elford. 1933. Observations on antiphage sera: II. Properties of incompletely neutralized phage. Brit. J. Exp. Pathol. 14: 376-383.
3. Arendrup, M., Sonnerborg, A., Svennerholm, B., Akerblom, L., Nielsen, C., Clausen, H., Olofsson, S., Nielsen, J. O., Hansen, J. E. 1993. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. J. Gen. Virol. 74(Pt 5): 855-863.
4. Bangham, C. R. M. 1995. The influence of immunity on virus evolution, pp. 150-164. Molecular Basis of Virus Evolution. A. J. Gibbs, C. H. Calisher and F. Garcia-Arenal. Cambridge, Cambridge University Press.
5. Bauer, G., McCaskill, J. S., Otten, H. 1989. Traveling waves of in vitro evolving RNA. Proc. Nat. Acad. Sci. 86(20): 7937-7941.
6. Benmansour, A., Brahimi, M., Tuffereau, C., Coulon, P., Lafay, F., Flamand, A. 1992. Rapid sequence evolution of street rabies glycoprotein is related to the highly heterogeneous nature of the viral population. Virology 187(1): 33-45.
7. Borrego, B., Novella, I. S., Giralt, E., Andreu, D., Domingo, E. 1993. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J. Virol. 67(10): 6071-6079.
8. Both, G. W., Sleigh, M. J., Cox, N. J., Kendal, A. P. 1983. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J. Virol. 48(1): 52-60.
9. Burnet, F. M., Keogh, E. V., Lush, D. 1937. Immunological reactions of filterable viruses. Austr. J. Exp. Biol. Med. Sci. 15: 227-314.
10. Carrillo, E., Rojas, E. R., Cavallaro, L., Schiappacassi, M., Campos, R. 1989. Modification of foot-and-mouth disease virus after serial passages in the presence of antiviral polyclonal sera. J. Virol. 171(2): 599-601.
11. Celis, E. and T. W. Chang. 1984. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen. Science 224: 297-299.
12. Coffin, J. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: 483-489.
13. Delbrück, M. 1945. Effects of specific antisera on the growth of bacterial viruses (bacteriophages). J. Bacteriol. 50: 137-150.
14. Domingo, E. 1989. RNA virus evolution and the control of viral disease. Fortschritte der Arzneimittelforschung. Progress in Drug Research 33: 93-133.
15. Domingo, E., Martinez-Salas, E., Sobrino, F., de la Torre, J. C., Portela, A., Ortin, J., Lopez-Galindez, C., Perez-Brena, P., Villanueva, N., Najera, R., VandePol, S., Steinhauer, D., DePolo, N., Holland, J. 1985. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance - a review. Gene 40: 1-8.
16. Duarte, E. A., Novella, I. S., Weaver, S. C., Domingo, E., Wain-Hobson, S., Clarke, D. K., Moya, A., Elena, S. F., de la Torre, J. C., Holland, J. J. 1994. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents. Dis. 3(4): 201-214.
17. Enomoto, N., Sato, C., Kurosaki, M., Marumo, F. 1994. Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene. J. Hepatol. 20(2): 252-261.
18. Goodenow, M., Huet, T., Saurin, W., Kwok, S., Sninsky, J., Wain-Hobson, S. 1989. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. Acq. Imm. Defic. Synd. 2(4): 344-352.
19. Holland, J., de la Torre, J. C., Clarke, D. K., Duarte, E. 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65(6): 2960-2967.
20. Holmes, E., Zhang, L. Q., Simmonds, P., Ludlam, C. A., Brown, A. J. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Nat. Acad. Sci. USA 89(11): 4835-4839.
21. Kawamura, H. and J. Berzofsky. 1986. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobin. J. Immunol. 136(1): 58-65.
22. Kilbourne, E. D. 1994. Host determination of viral evolution: a variable tautology, pp. 253-271. The evolutionary biology of viruses. S. S. Morse. N.Y., Raven Press.
23. Kong, D. and J. Yin. 1995. Whole-virus vaccine development by continuous culture on a complementing host. Bio/Technol. 13(6): 583-586.
24. Kruger, D. H., Mann, W., Hansen, S., Biasing, G., Blasing, M., Schroeder, C. 1988. A simple method of distinguishing the bacterial viruses T3 and T7, and a critical reevaluation of their heterologous and homologous exclusion. J. Basic Microbiol. 28: 45-53.
25. Lee, Y. and J. Yin. 1996a. Detection of Evolving Viruses. Nature Biotechnol. 14(4): 491-493.
26. Lee. Y. and J. Yin. 1996b. Imaging the Propagation of Viruses. Biotechnol. Bioeng. 52: 438-442.
27. Lindenmann, J. and G. E. Gifford. 1963. Studies on vaccinia virus plaque formation and its inhibition by interferon. I. Dynamics of plaque formation by vaccinia virus. J. Virol. 19: 283-293.
28. Martinez, M., Carrillo, C., Gonzalez-Candelas, F., Moya, A., Domingo, E., Sobrino, F. 1991. Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J. Virol. 65(7): 3954-3957.
29. Mateu, M., Martinez, M. A., Rocha, E., Andreu, D., Parejo, J., Giralt, E., Sobrino, F., Domingo, E. 1989. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Nat. Acad. Sci. USA 86(15): 5883-5887.
30. McKeating, J., Gow, J., Goudsmit, J., Pearl, L. H., Mulder, C., Weiss, R. A. 1989. Characterization of HIV-1 neutralization escape mutants. AIDS 3(12): 777-784.
31. Miller, J. H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor, Cold Spring Harbor Laboratory.
32. Munoz, J., Parks, W. P., Wolinsky, S. M., Korber, B. T., Hutto, C. 1993. HIV-1 reverse transcriptase. A diversity generator and quasispecies regulator. Ann. N.Y. Acad. Sci. 693: 65-70.
33. Novella, I., Duarte, E. A., Elena, S. F., Moya, A., Domingo, E., Holland, J. J. 1995. Exponential increases of RNA virus fitness during large population transmissions. Proc. Nat. Acad. Sci. USA 92: 5841-5844.
34. Nowak, M. 1992. Variability of HIV infections. J. Theo. Biol. 155(1): 1-20.
35. Perelson, A., Neumann, A., Markowitz, M., Leonard, J., Ho, D. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271(5255): 1582-1586.
36. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R., Rizza, C. R. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354(6353): 453-459.
37. Pokric, B., Sladic, S., Juros, S., Cajavec, S. 1993. Application of the immune complex for immune protection against viral disease. Vaccine 11(6): 655-659.
38. Rueda, P., Garcia-Barreno, B., Melero, J. A. 1994. Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). J. Virol. 198(2): 653-662.
39. Shimizu, Y., Hijikata, M., Iwamoto, A., Alter, H. J., Purcell, R. H., Yoshikura, H. 1994. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68(3): 1494-1500.
40. Sobrino, F., Palma, E. L., Beck, E., Davila, M., de la Torre, J. C., Negro, P., Villanueva, N., Ortin, E., Domingo, J. 1986. Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene 50: 149-159.
41. Strauss, E. G., Stec, D. S., Schmaljohn, A. L., Strauss, J. H. 1991. Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants. J. Virol. 65(9): 4654-4664.
42. Studier, F. W. 1969. The genetics and physiology of bacteriophage T7. Virology 39: 562-574.
43. Tao, B., Fultz, P. N. 1995. Molecular and biological analyses of quasispecies during evolution of a virulent simian immunodeficiency virus, SIVsmmPBj14. J. Virol. 69(4): 2031-2037.
44. Yamamoto, K., Horikita, M., Tsuda, F., Itoh, K., Akahane, Y., Yotsumoto, S., Okamoto, H., Miyakawa, Y., Mayumi, M. 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 68(4): 2671-2676.
45. Yin, J. 1991. A quantifiable phenotype of viral propagation. Biochem. Biophys. Res. Commun. 174(2): 1009-10014.
46. Yin, J. 1993. Evolution of Bacteriophage T7 in a Growing Plaque. J. Bacteriol. 175(5): 1272-1277.
47. Yin, J., McCaskill, J. S. 1992. Replication of viruses in a growing plaque: a reaction-diffusion model. J. Biophys. 61(6): 1540-1549.
48. Zebedee, S. L., Lamb, R. A. 1989. Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc. Nat. Acad. Sci. USA 86(3): 1061-1065.